1,000
Participants
Start Date
May 26, 2025
Primary Completion Date
April 30, 2035
Study Completion Date
April 30, 2035
Inspire UAS System
Participants will be implanted with the Inspire UAS System, which is a permanent, implantable therapy that consists of three implantable components: an IPG, a stimulation lead, and a sensing lead. In addition, the study subject receives a remote control to activate the therapy.
NOT_YET_RECRUITING
Klinikum Klagenfurt, KABEG, Klagenfurt
NOT_YET_RECRUITING
Ordensklinikum Linz, Linz
NOT_YET_RECRUITING
Universitair Ziekenhuis Antwerpen, Edegem
NOT_YET_RECRUITING
Angers University Hospital Center, Angers
NOT_YET_RECRUITING
CHU Grenoble Alpes, La Tronche
NOT_YET_RECRUITING
Clinique de la Louviere, Lille
NOT_YET_RECRUITING
Hôpital d'Instruction des Armées Laveran, Marseille
NOT_YET_RECRUITING
Clinique Beausoleil, Montpellier
NOT_YET_RECRUITING
CHU Saint Etienne, Saint-Priest-en-Jarez
RECRUITING
Asklepios Klinik Hamburg, Hamburg
RECRUITING
Universitatsklinikum Hamburg Eppendorf, Hamburg
NOT_YET_RECRUITING
Klinik für HNO-Heilkunde/HNO-Schlaflabor, Lübeck
NOT_YET_RECRUITING
Otto-von-Guericke-Universität Magdeburg, Magdeburg
NOT_YET_RECRUITING
Universitäts-HNO-Klinik Mannheim, Mannheim
RECRUITING
Klinikum Rechts der Isar Technische Universität München, Munich
NOT_YET_RECRUITING
Sint Lucas Andreas Ziekenhus (OLVG), Amsterdam
NOT_YET_RECRUITING
St. Antonius Ziekenhuis Nieuwegein, Nieuwegein
NOT_YET_RECRUITING
Kantonnspital Baselland-Liestal, Liestal
NOT_YET_RECRUITING
Guy's & St Thomas' NHS Foundation Trust, London
NOT_YET_RECRUITING
University College London Hospitals NHS Foundation Trust, London
NOT_YET_RECRUITING
Manchester University NHS Trust, Manchester
Lead Sponsor
Inspire Medical Systems, Inc.
INDUSTRY